Intellectual Property Rights
CIPLA Ltd. v. CIPLA Industries Pvt. Ltd. & Ors.
2017 (69) PTC 425 (Bom) (FB)
- Citation
- 2017 (69) PTC 425 (Bom) (FB)
- Court
- Bombay High Court
- Date
- 1 March 2017
- Bench
- Full Bench: Manjula Chellur C.J., G.S. Kulkarni and N.M. Jamdar JJ.
Facts
- CIPLA Ltd. was a well-known pharmaceutical company.
- It owned registrations for the mark CIPLA, principally in relation to pharmaceutical and medicinal preparations.
- CIPLA Industries Pvt. Ltd. used:
- CIPLA as part of its corporate or trade name;
- marks such as CIPLA PLAST;
- in relation to household goods including soap dishes, photo frames and ladders.
- The goods were different from pharmaceutical products.
- CIPLA Ltd. sued for infringement and passing off.
- A legal question arose regarding the interaction between:
- Section 29(4), concerning reputed marks used on dissimilar goods;
- Section 29(5), concerning use of a registered mark as a trade or business name.
- An earlier Bombay High Court decision in Raymond had created uncertainty.
- The matter was referred to a Full Bench.
Issue
- Whether use of a registered mark as part of a corporate or trade name is governed exclusively by Section 29(5).
- Whether Section 29(4) can be used where the trade-name user deals in dissimilar goods.
- Whether CIPLA Ltd. could establish statutory infringement despite the parties’ different goods.
Rule
- Section 29 contains distinct forms of trademark infringement.
- Section 29(5) specifically addresses use of a registered trademark:
- as a trade name;
- as part of a business concern’s name.
- Under Section 29(5), infringement occurs where the defendant deals in goods or services in respect of which the mark is registered.
- Section 29(4) applies to use of a reputed mark in relation to dissimilar goods or services, subject to its cumulative conditions.
- A specific statutory provision governing trade-name use cannot ordinarily be bypassed through a more general provision.
- The different sub-sections must be interpreted harmoniously without rendering Section 29(5) meaningless.
- Statutory infringement and passing off remain distinct.
- Failure under Section 29 does not necessarily eliminate a passing-off claim.
Application
- The defendants used CIPLA principally as part of their corporate or trade identity.
- This brought the conduct directly within the subject addressed by Section 29(5).
- CIPLA Ltd.’s registrations concerned pharmaceutical goods.
- The defendants dealt in household and plastic products rather than those registered goods.
- The requirement in Section 29(5) was therefore not satisfied.
- CIPLA Ltd. argued that Section 29(4) should apply because:
- its mark had reputation;
- the defendants used it on dissimilar goods;
- the use took unfair advantage of that reputation.
- The Full Bench rejected that route for the particular trade-name use.
- If Section 29(4) were applied whenever Section 29(5) failed, the carefully drafted limitation in Section 29(5) would have no purpose.
- Parliament specifically required identity between the defendant’s business field and the goods or services covered by registration when the complaint concerned a trade name.
- The court could not remove that requirement through interpretation.
- The decision did not grant a general licence to imitate famous corporate names.
- CIPLA Ltd. could still pursue:
- passing off;
- other statutory provisions where independently applicable;
- relief against trademark use distinct from use merely as a business name.
- The reference concerned the proper statutory route, not the final merits of every possible claim.
Conclusion
- The Full Bench held that Section 29(5) specifically and exhaustively governs infringement through use of a registered mark as a trade or business name.
- Section 29(4) could not be invoked to overcome the requirement that the defendant deal in goods or services covered by the registration.
- The earlier contrary understanding in Raymond was not accepted.
- Use this case for: where the complained-of use is as a corporate or trade name, Section 29(5) governs and cannot be bypassed through the dilution provision in Section 29(4).